Prophotonix Share Discussion Threads

[greedy rooster] 01/9/2017 15:49

Herald on board, that's not bade news.

[buywell3] 31/8/2017 18:47

POST REMOVED

[rcturner2] 31/8/2017 14:17

six have sold their stake here

[wilmdav] 20/8/2017 00:14

"The plan performance is measured annually and over the three-year period ending December 31, 2019 with vesting at various levels based on performance; vesting levels range from zero to the maximum as shown in the table above."

Does this mean the exercise price is fixed at $0.2385 (18.25p) but subject also to achievement of various levels of growth in EBITDA over 3 years to 31/12/199?

[greedy rooster] 18/8/2017 07:58

look idiot, they're protecting themselves from being taken over on the cheap.

[buywell3] 18/8/2017 07:24

POST REMOVED

[briangeeee] 17/8/2017 21:41

It's a preparation necessary for SIXH to sell their holding, should they ever wish to do so, or for the company itself to issue new shares. Given that SIXH aren't in a great state, they're probably looking to raise some cash by selling. Less likely that the company itself would use it to issue new Reg S equity, but who knows.

The announcement should certainly have better explained the reason.

[buywell3] 17/8/2017 18:53

POST REMOVED

[skirbell] 17/8/2017 09:07

I've never seen this before, so struggling to fully digest it. However, some initial thoughts.

It doesn't appear to be dilution as 22M shares are being transferred to Restricted Stock - if so, who currently owns the shares that are being made Restricted?

The Restricted shares limit hedging. Would this include shorting or loaning for shorting? Does PPIX suffer from a large short position?

Restricted shares cannot be sold in the US or to a US person. This potentially reduces the opportunity for a take over from a US company. Are PPIX concerned that they might be taken out?

At a guess, this looks like a move to reduce volatility in the share price going forward. And/or to protect against US take overs?

[rcturner2] 17/8/2017 08:33

Anyone got any comments on the rns?

[greedy rooster] 20/7/2017 08:06

Strong trading in the photonics division at IQE bodes well for PPIX. We've invested future growth and can sit back and enjoy a return on that investment over the coming months.

[greedy rooster] 19/7/2017 08:06

I take it you didn't sell well.

[buywell3] 18/7/2017 16:37

Yes but if you can't even get the name right in your header

Who is going to take any note of what you say ?

This is a very basic error and shows lack of attention to detail ......... 4/10

ProPhotonix....... Lighting the way ahead

[greedy rooster] 18/7/2017 16:12

Good to see solid volume today, edging back up - still cheap and up for sale as far as I'm concerned.

[buywell3] 17/7/2017 07:48

POST REMOVED

[captain of the titanic] 14/7/2017 11:50

Oh dear


You have been forwood (cursed). Call the funeral director.

[greedy rooster] 14/7/2017 10:29

What, trading in line with expectations 'kills' your potential investment - good luck!

[dr biotech] 14/7/2017 10:07

Its always a danger to have a few customers making up a large proportion of sales. I worked for a small company where 20% of orders for two years were from one customer who had a one off product. When that stopped it suddenly made our sales look very poor and we lost the supplier contract.

A typical use of the laser diode is as a robotic sensor - essentially it switches on/off when the robot reaches the home position or the edge of its movement. Many other similar sensing applications too. Without knowing the product that was replaced with different tech its impossible to know whether this was a one off loss or if its now outdated (I'd tend to think the former)

My concern here is that the company is being run for the benefit of the directors rather than the shareholders - its fair to say this update has killed my potential investment, but good luck to those that remain.

[greedy rooster] 14/7/2017 09:43

Cobra products due for sale from Q3.
This puppy looks fine.

[rcturner2] 14/7/2017 09:31

Even with the loss of the customer, revenue was up 4% in the period.

[varies] 14/7/2017 09:29

Now that the price of PPIX shares has fallen from 18.5p (early June) to 8.5p, the award of 12,870,000 options at 23.85c, say 18.5p, does not seem such as generous as it did.
The treatment of this award in the Profit & Loss account should presumably be calculated in accordance with some formula in which one factor is the average share price during the accounting period. PPIX indicate a figure of $100,000 per month; will this relate to the last 6 months of 2017 or the whole year ?
Unless the share price recovers soon, the average for 2017 is unlikely to exceed 10p, say 13c, in which case a fair value for the award might be 1c per option, say $128,700, and would be the charge for the full year and not just one month.
So I find the $100,000 per month figure perplexing.
This is not, of course, a cash charge; it is just an unwelcome reduction of the share of profits going to outsiders like ourselves.
The increase in expenditure on R&D and sales and loss of an important customer will affect our cash flow this year and seem more important than the award of options.

[cezary2] 14/7/2017 09:14

People selling? Why?

[pauliewonder] 14/7/2017 08:11

Down 31% on £13k worth of trades!! Completely unjustified and unfair

[greedy rooster] 14/7/2017 08:08

Trading in line, stock down 40% so back to a p/e of 6.

[buywell3] 14/7/2017 08:04

POST REMOVED